Gioacchino Angarano
Overview
Explore the profile of Gioacchino Angarano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
1224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Gennaro F, Segala F, Guido G, Poliseno M, De Santis L, Belati A, et al.
PLoS One
. 2024 Apr;
19(4):e0301297.
PMID: 38640112
High School students, recognized as a high-risk group for sexually transmitted infections (STIs), were the focal point of an educational campaign in Southern Italy to share information and good practices...
2.
Babiloni C, Percio C, Lizio R, Lopez S, Pennica A, Roma P, et al.
Brain Res Bull
. 2022 Feb;
181:129-143.
PMID: 35101575
Previous evidence showed abnormal parietal sources of resting-state electroencephalographic (EEG) delta (< 4 Hz) and alpha (8-12 Hz) rhythms in treatment-Naïve HIV (Naïve HIV) subjects, as cortical neural synchronization markers...
3.
Bavaro D, Balena F, Ronga L, Signorile F, Romanelli F, Stolfa S, et al.
J Mycol Med
. 2021 Oct;
32(1):101206.
PMID: 34624594
An increased number of patients is at risk of Candida spp. bloodstream infection (CBSI) in modern medicine. Moreover, the rising of antifungal resistance (AR) was recently reported. All consecutive CBSI...
4.
Bavaro D, Pizzutilo P, Catino A, Signorile F, Pesola F, Di Gennaro F, et al.
Open Forum Infect Dis
. 2021 Jun;
8(6):ofab187.
PMID: 34141817
Background: Immune checkpoint inhibitors (ICIs) have revolutionized nonsmall cell lung cancer (NSCLC) treatment and significantly increased overall survival of patients. However, the incidence of concurrent infections and their management is...
5.
Poliseno M, Bavaro D, Brindicci G, Luzzi G, Carretta D, Spinarelli A, et al.
Clin Drug Investig
. 2021 Apr;
41(5):437-448.
PMID: 33884583
Background And Objectives: The study aimed to evaluate the impact of dalbavancin therapy on both hospital length-of-stay (LOS) and treatment-related costs, as well as to describe the clinical outcome, in...
6.
Scardapane A, Villani L, Bavaro D, Passerini F, Ianora A, Lucarelli N, et al.
Biomed Res Int
. 2021 Mar;
2021:8851736.
PMID: 33778084
Purpose: This study is aimed at assessing the prevalence of pulmonary artery filling defects (PAFDs) consistent with pulmonary artery embolism (PAE) in patients with SARS-CoV-2 infection and at investigating possible...
7.
Poliseno M, Bavaro D, Di Gennaro F, De Vita G, Girardi E, Saracino A, et al.
AIDS Care
. 2020 Nov;
33(12):1621-1626.
PMID: 33242983
The loss of patients to follow up is a major issue related to HIV management. Our research was aimed to evaluate, in a single Italian centre, the rate of patients...
8.
Galli L, Parisi M, Poli A, Menozzi M, Fiscon M, Garlassi E, et al.
Open Forum Infect Dis
. 2020 Nov;
7(11):ofaa456.
PMID: 33241063
Background: Currently, no data are available on the burden of morbidity and mortality in people with HIV-1 (PWH) harboring a 4-class drug-resistant (4DR) virus (nucleoside reverse transcriptase inhibitors, non-nucleoside reverse...
9.
Gaining Back What Is Lost: Recovering the Sense of Smell in Mild to Moderate Patients After COVID-19
Iannuzzi L, Salzo A, Angarano G, Palmieri V, Portincasa P, Saracino A, et al.
Chem Senses
. 2020 Oct;
45(9):875-881.
PMID: 33033827
The purpose of our cohort study was to quantify olfactory deficits in Coronavirus disease 2019 (COVID-19) patients using Sniffin' Sticks and a pre-post design to evaluate olfactory recovery. Thirty adult...
10.
Bollo L, Guerra T, Bavaro D, Monno L, Saracino A, Angarano G, et al.
J Neurol Sci
. 2020 Jul;
416:117011.
PMID: 32650143
No abstract available.